Literature DB >> 19513588

Comparative 1H NMR-based metabonomic analysis of HIV-1 sera.

C Philippeos1, F E Steffens, D Meyer.   

Abstract

(1)H NMR spectroscopy of sera from HIV-1 infected and uninfected individuals was performed on 300 and 600 MHz instruments. The resultant spectra were automatically data reduced to 90 and 180 integral segments of equal length. Analysis of variance identified significant differences between the sample groups, especially for the samples analyzed on 600 MHz and reduced to fewer segments. Linear discriminant analysis correctly classified 100% of the samples analyzed on the 300 MHz NMR (reduced to 180 segments); an increase in instrument sensitivity resulted in lower percentages of correctly classified samples. Multinomial logistic regression (MLR) resulted in 100% correct classification of all samples from both instruments. Thus (1)H-NMR metabonomics on either instrument distinguishes HIV-positive individuals using or not using anti retroviral therapy, but the sensitivity of the instrument impacts on data reduction. Furthermore, MLR is a novel multivariate statistical technique for improved classification of biological data analyzed in NMR.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19513588     DOI: 10.1007/s10858-009-9329-8

Source DB:  PubMed          Journal:  J Biomol NMR        ISSN: 0925-2738            Impact factor:   2.835


  11 in total

Review 1.  'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data.

Authors:  J K Nicholson; J C Lindon; E Holmes
Journal:  Xenobiotica       Date:  1999-11       Impact factor: 1.908

2.  Analytical reproducibility in (1)H NMR-based metabonomic urinalysis.

Authors:  Hector C Keun; Timothy M D Ebbels; Henrik Antti; Mary E Bollard; Olaf Beckonert; Götz Schlotterbeck; Hans Senn; Urs Niederhauser; Elaine Holmes; John C Lindon; Jeremy K Nicholson
Journal:  Chem Res Toxicol       Date:  2002-11       Impact factor: 3.739

3.  Rapid and noninvasive diagnosis of the presence and severity of coronary heart disease using 1H-NMR-based metabonomics.

Authors:  Joanne T Brindle; Henrik Antti; Elaine Holmes; George Tranter; Jeremy K Nicholson; Hugh W L Bethell; Sarah Clarke; Peter M Schofield; Elaine McKilligin; David E Mosedale; David J Grainger
Journal:  Nat Med       Date:  2002-11-25       Impact factor: 53.440

Review 4.  Metabonomics: a platform for studying drug toxicity and gene function.

Authors:  Jeremy K Nicholson; John Connelly; John C Lindon; Elaine Holmes
Journal:  Nat Rev Drug Discov       Date:  2002-02       Impact factor: 84.694

5.  Applying biofluid 1H NMR-based metabonomic techniques to distinguish between HIV-1 positive/AIDS patients on antiretroviral treatment and HIV-1 negative individuals.

Authors:  R Hewer; J Vorster; F E Steffens; D Meyer
Journal:  J Pharm Biomed Anal       Date:  2006-04-18       Impact factor: 3.935

6.  Measurement of biomolecular diffusion coefficients in blood plasma using two-dimensional 1H-1H diffusion-edited total-correlation NMR spectroscopy.

Authors:  M Liu; J K Nicholson; J A Parkinson; J C Lindon
Journal:  Anal Chem       Date:  1997-04-15       Impact factor: 6.986

7.  The AIDS dementia complex: II. Neuropathology.

Authors:  B A Navia; E S Cho; C K Petito; R W Price
Journal:  Ann Neurol       Date:  1986-06       Impact factor: 10.422

8.  Elevated subcortical choline metabolites in cognitively and clinically asymptomatic HIV+ patients.

Authors:  D J Meyerhoff; C Bloomer; V Cardenas; D Norman; M W Weiner; G Fein
Journal:  Neurology       Date:  1999-03-23       Impact factor: 9.910

9.  750 MHz 1H and 1H-13C NMR spectroscopy of human blood plasma.

Authors:  J K Nicholson; P J Foxall; M Spraul; R D Farrant; J C Lindon
Journal:  Anal Chem       Date:  1995-03-01       Impact factor: 6.986

Review 10.  Hyperlipidaemia in patients with HIV-1 infection receiving highly active antiretroviral therapy: epidemiology, pathogenesis, clinical course and management.

Authors:  Leonardo Calza; Roberto Manfredi; Francesco Chiodo
Journal:  Int J Antimicrob Agents       Date:  2003-08       Impact factor: 5.283

View more
  7 in total

Review 1.  Metabolomics: Applications and Promise in Mycobacterial Disease.

Authors:  Mehdi Mirsaeidi; Mohammad Mehdi Banoei; Brent W Winston; Dean E Schraufnagel
Journal:  Ann Am Thorac Soc       Date:  2015-09

2.  A combined chemometric and quantitative NMR analysis of HIV/AIDS serum discloses metabolic alterations associated with disease status.

Authors:  Tracy R McKnight; Hikari A I Yoshihara; Lungile J Sitole; Jeffery N Martin; Francois Steffens; Debra Meyer
Journal:  Mol Biosyst       Date:  2014-11

3.  Pattern recognition analysis of proton nuclear magnetic resonance spectra of brain tissue extracts from rats anesthetized with propofol or isoflurane.

Authors:  Hiroshi Kawaguchi; Keiko Hirakawa; Kensuke Miyauchi; Kaoru Koike; Youkichi Ohno; Atsuhiro Sakamoto
Journal:  PLoS One       Date:  2010-06-17       Impact factor: 3.240

4.  Mid-ATR-FTIR spectroscopic profiling of HIV/AIDS sera for novel systems diagnostics in global health.

Authors:  Lungile Sitole; Francois Steffens; Tjaart P J Krüger; Debra Meyer
Journal:  OMICS       Date:  2014-06-17

Review 5.  Metabolomics in infectious diseases and drug discovery.

Authors:  Vivian Tounta; Yi Liu; Ashleigh Cheyne; Gerald Larrouy-Maumus
Journal:  Mol Omics       Date:  2021-06-14

6.  Nuclear magnetic resonance based profiling of biofluids reveals metabolic dysregulation in HIV-infected persons and those on anti-retroviral therapy.

Authors:  Saif Ullah Munshi; Bharat Bhushan Rewari; Neel Sarovar Bhavesh; Shahid Jameel
Journal:  PLoS One       Date:  2013-05-16       Impact factor: 3.240

7.  Plasma metabolomic study in perinatally HIV-infected children using 1H NMR spectroscopy reveals perturbed metabolites that sustain during therapy.

Authors:  Urvinder Kaur S; Bolaji Fatai Oyeyemi; Anita Shet; Bindu Parachalil Gopalan; Himanshu D; Neel Sarovar Bhavesh; Ravi Tandon
Journal:  PLoS One       Date:  2020-08-31       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.